Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4182233 | L'Encéphale | 2009 | 10 Pages |
Abstract
Patients on antipsychotic drugs should undergo regular testing of blood sugar, lipid profile, as well as body weight, waist circumference and blood pressure, with recommended time intervals between measures. Clinicians should track the effects of treatment on physical and biological parameters, and should facilitate access to appropriate medical care. In order to prevent or limit possible side effects, information must be given to the patient and his family on the cardiovascular and metabolic risks. The cost-effectiveness of implementing these recommendations is considerable: the costs of laboratory tests and additional equipment costs (such as scales, tape measures, and blood pressure devices) are modest. The issue of responsibility for monitoring for metabolic abnormalities is much debated. However, with the prescription of antipsychotic drugs comes the responsibility for monitoring potential drug-induced metabolic abnormalities. The onset of metabolic disorders will imply specific treatments. A coordinated action of psychiatrists, general practitioners, endocrinologists, cardiologists, nurses, dieticians, and of the family is certainly a key determinant to ensure the optimal care of these patients.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
D. Saravane, B. Feve, Y. Frances, E. Corruble, C. Lancon, P. Chanson, P. Maison, J.-L. Terra, J.-M. Azorin, avec le soutien institutionnel du laboratoire Lilly avec le soutien institutionnel du laboratoire Lilly,